Close Menu

NEW YORK — Zymo Research said on Tuesday that it has received CE-IVD marking for its Quick SARS-CoV-2 Multiplex Kit.

The real-time reverse transcription PCR test is designed for the qualitative detection of SARS-CoV-2 nucleic acid in upper and lower respiratory specimens. According to the Irvine, California-based company, the kit has a limit of detection of 10-virus copies per reaction and up to 382 samples can be analyzed for each RT-PCR run.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.